Sponsorship verdict
No sponsorship evidence yet
No government record and no wording either way. Not a refusal: ask the recruiter.
-
?
No government sponsor record hereNo government sponsor record covers this employer in this country.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
Can’t check pay against the visa rulesNo salary stated. Germany EU Blue Card needs at least €50,700 a year (shortage-occupation / recent-graduate: €45,934).
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Can’t check pay against the visa rules
- No salary stated. Germany EU Blue Card needs at least €50,700 a year (shortage-occupation / recent-graduate: €45,934). Source: https://www.make-it-in-germany.com/en/visa-residence/types/eu-blue-card, rules effective 2026-01-01.
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
Before you apply
Sponsorship unknown
No register record and no sponsorship wording in the posting. Worth asking the employer before investing significant time.
These come from the posting’s own wording. Read the original listing to confirm. See better-fit alternatives →
About the role
Why Join Us?
Be a hero for our rare disease patients
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.
If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team .
Position Summary:
ultra innovative – Tackle rare and dynamic challenges
The Ultra Care Liaison (UCL) is a field-based function on the Ultragenyx DACH team , combining responsibilities at the intersection of scientific engagement and non-promotional market access across the portfolio. The key objective of this role is to improve patient care in the assigned geographic territory by providing stakeholder-specific information, education and support, as needed and requested. The UCL will act as the primary point of contact for selected HCPs. This role requires the ability to identify and interact with selected HCPs in person and remotely, a patient-centric attitude, a strong scientific background , strategic communication skills , and the ability to establish, nurture and maintain relationships across health care ecosystems at various levels.
Work Model:
Field: Officially documented as working as a member of the Ultragenyx field team, generally interacting with third parties on behalf of Ultragenyx.
Responsibilities:
• Proactively engage in disease awareness, disease state and patient referral education, including patient transition from pediatric to adult care, with physicians, other relevant HCPs, pharmacists, nurses and dietitians in therapeutic areas of interest for Ultragenyx.
• Reactively educate physicians and other relevant HCPs, pharmacists, nurses, dietitians and payers about the latest scientific evidence on EU Commission-approved and non-EU Commission-approved Ultragenyx medications.
• Reactively educate and engage in scientific exchange with physicians, other relevant HCPs and payers about the latest scientific evidence on the diagnosis of the therapeutic areas of focus.
• Organize and execute local educational events and roundtables to foster compliant dissemination of disease awareness, disease state education and product-related medical and scientific evidence developed and/or validated by Medical Affairs, and to support networking in the scientific community in the assigned territory.
• Facilitate peer-to-peer exchange between HCPs within the assigned territory on the current evidence in therapeutic areas of focus.
• Respond to product-related inquiries from HCPs and pharmacists within the scope of the approved label or scientific evidence, if no label is available, as well as inquiries on disease awareness, market access and supply chain topics.
• Assess the ability of hospitals to administer gene therapies, a
Apply on company site ↗